In fields as varied as clean energy, electronics, engineering and medicine. Fusion IP owns the rights to an amazing depth and quality of research from two of the UK's leading universities. Enabling us to invest in some of the world's most advanced and exciting science and turn world class research into business.

We work in a number of sectors including:

Featured company case study

Improved cell therapy for the treatment of traumatic knee injuries that damage the articular cartilage.

David Baynes, CEO of Fusion IP, talks about their projects with Simcyp, Magnomatics and others

David Baynes